FDA Approves Drug Made From Gene-Tweaked Goats

Landmark decision could signal start of large-scale 'pharming' for drugs

By Rob Quinn, Newser Staff

Posted Feb 7, 2009 7:07 AM CST

(Newser) – An FDA decision to approve a drug made from genetically engineered goats is being called a milestone decision likely to lead to many more "pharm animals," the Boston Globe reports. Biotech firm GTC says the milk from a single genetically modified goat can... Read full story »

COMMENTS

Read the comment policy

You need to Log in to Newser to comment. Don't have an account yet? Sign up now!

5 comments

A snapshot of the day's best news stories.

View Larger Grid

All Today Yesterday Pick a Date

What's Popular Now on Facebook

Miami Face-Eater Identified

'Serpent Pastor' Dies of Snake Bite

Boston Globe (Source Grid »)
New York Times (Source Grid »)

Goats engineered to produce drug in milk
WebMD

FDA creates new guidelines on genetically modified animals
Los Angeles Times

Health

genetic modification • livestock • biotechnology • prescription drugs • pharmaceutical • goats • pharmaceutical industry

More Newser Stories

Engineered Goats May Usher In New Age of Drugs

Animals' bodies act as processors for key protein

(NEWSER) - Goats could be the pharma factories of tomorrow: Genetic engineering can prompt them to make a protein in their milk to fight excessive blood clotting. A medication culled from the process was greeted warmly yesterday by an expert panel, and now the FDA is looking into it. If approved, the drug, ATryn, could be the first of many meds derived from genetically-engineered goats, rabbits, and other creatures, the Los Angeles Times reports. More»

We Should Pay for Drugs Only If They Work

Biotech exec Samuel Waksal argues for a pay-for-results system

(NEWSER) - Medical costs, and especially drug costs, are scandalously high in the US, but just capping them isn't the answer, biotech exec Samuel Waksal writes in the New York Times . "Individuals and insurance companies should be willing to pay—and pay a lot—for drugs when they work," he argues. "The problem is we’re also paying for drugs when they don’t." His solution: Patients should only pay for drugs when they actually prove effective for them. More»

As Lipitor Patent Expires, Pfizer Fights to Keep Users

Cholesterol drug's price should be coming down soon

(NEWSER) - The biggest-selling drug of all time—Lipitor—is now available for production in generic form as Pfizer's patent on the cholesterol-lowering pill expired today, reports AFP . It's such a huge money-maker for Pfizer, however, that the company is rolling out all kinds of discounts and incentives to keep its 9 million users from switching, notes AP . Lipitor currently costs about $120 per month, and that should steadily decrease. More»

Global Patent Pool Scores 4 New AIDS Drugs

It's a major step to benefit poor nations battling disease

(NEWSER) - Gilead Sciences announced today that it will license four AIDS and hepatitis B drugs to an international patent pool, allowing cheap, generic versions to be produced for sale in low-income countries. The AIDS drugs, which include tenofovir and emtricitabine, represent a major upgrade on the treatments currently available in those countries, the New York Times reports. The move makes Gilead the first major drug manufacturer to contribute to the Medicines Patent Pool. More»

Drug Labels List an Average 70 Side Effects

Pharmaceutical companies trying to protect themselves from litigation

(NEWSER) - Take a gander at your typical prescription drug label, and you’ll see a lot more side effects than even the fastest talker could rattle off at the end of a commercial. The average label warns of a staggering 70 side effects, according to a new study that reviewed 5,600 such labels. But that’s mostly because drug makers want to protect themselves from every possible lawsuit, rather than because of real dangers, researchers tell Live Science . More»

NEWS FROM OUR PARTNERS

What is Newser?

Face it: there's too much news. At Newser, we choose the most thought-provoking and entertaining stories from hundreds of US and international sources and reduce them to a headline, picture, and two paragraphs. And we do it 24/7—you can come back morning, noon, night (and in between) for something new that matters. Read less, know more.

Learn more »

Partnering with: Slate

View Newser on the mobile website

FDA Approves Drug Made From Gene-Tweaked Goats

Landmark decision could signal start of large-scale 'pharming' for drugs

genetic modification • livestock • biotechnology • prescription drugs • pharmaceutical • goats • pharmaceutical industry

MOST POPULAR STORIES

[ By Views ]

[ By Comments ]

More Newser Stories

Engineered Goats May Usher In New Age of Drugs

Animals' bodies act as processors for key protein

We Should Pay for Drugs Only If They Work

Biotech exec Samuel Waksal argues for a pay-for-results system

As Lipitor Patent Expires, Pfizer Fights to Keep Users

Cholesterol drug's price should be coming down soon

Global Patent Pool Scores 4 New AIDS Drugs

It's a major step to benefit poor nations battling disease

Drug Labels List an Average 70 Side Effects

Pharmaceutical companies trying to protect themselves from litigation

About Us

Site

Community

Site Maps

Tools

More News

What is Newser?